A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Novo Nordisk A S stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 475,490 shares of NVO stock, worth $51.2 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
475,490
Previous 276,599 71.91%
Holding current value
$51.2 Million
Previous $39.5 Million 43.4%
% of portfolio
0.25%
Previous 0.2%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$119.07 - $145.42 $23.7 Million - $28.9 Million
198,891 Added 71.91%
475,490 $56.6 Million
Q2 2024

Jul 30, 2024

BUY
$122.71 - $146.91 $3.96 Million - $4.74 Million
32,298 Added 13.22%
276,599 $39.5 Million
Q1 2024

May 01, 2024

BUY
$102.11 - $135.92 $5.72 Million - $7.62 Million
56,060 Added 29.78%
244,301 $31.4 Million
Q4 2023

Jan 24, 2024

SELL
$87.78 - $105.45 $207,511 - $249,283
-2,364 Reduced 1.24%
188,241 $19.5 Million
Q3 2023

Oct 26, 2023

BUY
$90.94 - $199.54 $9.42 Million - $20.7 Million
103,545 Added 118.94%
190,605 $17.3 Million
Q2 2023

Aug 10, 2023

BUY
$155.98 - $172.65 $3.51 Million - $3.88 Million
22,495 Added 34.84%
87,060 $14.1 Million
Q1 2023

May 04, 2023

SELL
$132.34 - $159.14 $16.3 Million - $19.5 Million
-122,832 Reduced 65.55%
64,565 $10.3 Million
Q4 2022

Feb 09, 2023

BUY
$102.55 - $135.33 $9.87 Million - $13 Million
96,291 Added 105.69%
187,397 $25.4 Million
Q3 2022

Nov 10, 2022

SELL
$95.28 - $116.93 $2.2 Million - $2.7 Million
-23,077 Reduced 20.21%
91,106 $9.1 Million
Q2 2022

Jul 26, 2022

BUY
$103.24 - $121.81 $5.22 Million - $6.16 Million
50,584 Added 79.54%
114,183 $10.1 Million
Q1 2022

May 10, 2022

SELL
$93.1 - $112.54 $77,366 - $93,520
-831 Reduced 1.29%
63,599 $7.06 Million
Q4 2021

Feb 08, 2022

SELL
$95.88 - $117.08 $241,138 - $294,456
-2,515 Reduced 3.76%
64,430 $7.22 Million
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $235,278 - $297,149
2,787 Added 4.34%
66,945 $6.43 Million
Q2 2021

Aug 11, 2021

SELL
$67.66 - $84.76 $76,726 - $96,117
-1,134 Reduced 1.74%
64,158 $5.37 Million
Q1 2021

May 13, 2021

SELL
$67.06 - $75.82 $35.4 Million - $40 Million
-527,851 Reduced 88.99%
65,292 $4.4 Million
Q4 2020

Feb 10, 2021

BUY
$63.89 - $73.8 $16.8 Million - $19.5 Million
263,648 Added 80.02%
593,143 $41.4 Million
Q3 2020

Nov 12, 2020

BUY
$63.69 - $70.22 $1.42 Million - $1.56 Million
22,246 Added 7.24%
329,495 $22.8 Million
Q2 2020

Aug 11, 2020

BUY
$58.54 - $67.94 $11.5 Million - $13.3 Million
195,949 Added 176.05%
307,249 $20.1 Million
Q1 2020

May 12, 2020

SELL
$49.46 - $64.78 $977,824 - $1.28 Million
-19,770 Reduced 15.08%
111,300 $6.7 Million
Q4 2019

Feb 12, 2020

BUY
$49.86 - $58.26 $3.23 Million - $3.77 Million
64,793 Added 97.76%
131,070 $7.59 Million
Q1 2019

May 13, 2019

BUY
$46.36 - $52.63 $494,012 - $560,825
10,656 Added 19.16%
66,277 $3.47 Million
Q4 2018

Feb 11, 2019

SELL
$41.54 - $47.25 $1.65 Million - $1.87 Million
-39,616 Reduced 41.6%
55,621 $2.56 Million
Q3 2018

Nov 13, 2018

BUY
$46.76 - $51.24 $1.19 Million - $1.31 Million
25,488 Added 36.54%
95,237 $4.49 Million
Q2 2018

Aug 14, 2018

SELL
$44.29 - $50.42 $1.91 Million - $2.17 Million
-43,078 Reduced 38.18%
69,749 $3.22 Million
Q1 2018

May 10, 2018

BUY
$48.49 - $58.14 $371,821 - $445,817
7,668 Added 7.29%
112,827 $5.56 Million
Q4 2017

Feb 12, 2018

BUY
$47.53 - $53.73 $1.56 Million - $1.77 Million
32,910 Added 45.55%
105,159 $5.64 Million
Q3 2017

Nov 08, 2017

BUY
$41.15 - $49.22 $248,628 - $297,387
6,042 Added 9.13%
72,249 $3.48 Million
Q2 2017

Aug 14, 2017

BUY
N/A
66,207
66,207 $2.83 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $243B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.